NIAID | Technology Transfer

Lutzomyia Longipalpis Polypeptides and Methods of Use

Read more about Lutzomyia Longipalpis Polypeptides and Methods of Use

France
09158294.0
Filed on 2009-04-20

Lutzomyia Longipalpis Polypeptides and Methods of Use

Read more about Lutzomyia Longipalpis Polypeptides and Methods of Use

Spain
09158294.0
Filed on 2009-04-20

Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Ireland
03752537.5
Filed on 2003-09-18

Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

United Kingdom
03752537.5
Filed on 2003-09-18

Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

France
03752537.5
Filed on 2003-09-18

Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Germany
03752537.5
Filed on 2003-09-18

Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Read more about Recovery of Recombinant Human Parainflunza Virus Type 2 (HPIV2) from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens

Switzerland
03752537.5
Filed on 2003-09-18

LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE

Read more about LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE

US Patent 9,120,867
Filed on 2013-12-05

Development Of Dengue Virus Vaccine Components

Read more about Development Of Dengue Virus Vaccine Components

Australia
2013263788
Filed on 2013-11-28

METHOD FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION

Read more about METHOD FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION

US Patent 9,415,105
Filed on 2013-10-30

Subscribe to NIAID